Copyright Reports & Markets. All rights reserved.

Global Implantable Drug Delivery Devices Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Implantable Drug Delivery Devices Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Implantable Drug Delivery Devices Market Size Growth Rate by Product
      • 1.4.2 Biodegradable
      • 1.4.3 Non-biodegradable
    • 1.5 Market by End User
      • 1.5.1 Global Implantable Drug Delivery Devices Market Size Growth Rate by End User
      • 1.5.2 Contraception
      • 1.5.3 Ophthalmology
      • 1.5.4 Cardiovascular
      • 1.5.5 Diabetes
      • 1.5.6 Oncology
      • 1.5.7 Autoimmune Diseases
      • 1.5.8 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Implantable Drug Delivery Devices Market Size
      • 2.1.1 Global Implantable Drug Delivery Devices Revenue 2014-2025
      • 2.1.2 Global Implantable Drug Delivery Devices Sales 2014-2025
    • 2.2 Implantable Drug Delivery Devices Growth Rate by Regions
      • 2.2.1 Global Implantable Drug Delivery Devices Sales by Regions
      • 2.2.2 Global Implantable Drug Delivery Devices Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Implantable Drug Delivery Devices Sales by Manufacturers
      • 3.1.1 Implantable Drug Delivery Devices Sales by Manufacturers
      • 3.1.2 Implantable Drug Delivery Devices Sales Market Share by Manufacturers
      • 3.1.3 Global Implantable Drug Delivery Devices Market Concentration Ratio (CR5 and HHI)
    • 3.2 Implantable Drug Delivery Devices Revenue by Manufacturers
      • 3.2.1 Implantable Drug Delivery Devices Revenue by Manufacturers (2014-2019)
      • 3.2.2 Implantable Drug Delivery Devices Revenue Share by Manufacturers (2014-2019)
    • 3.3 Implantable Drug Delivery Devices Price by Manufacturers
    • 3.4 Implantable Drug Delivery Devices Manufacturing Base Distribution, Product Types
      • 3.4.1 Implantable Drug Delivery Devices Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Implantable Drug Delivery Devices Product Type
      • 3.4.3 Date of International Manufacturers Enter into Implantable Drug Delivery Devices Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Implantable Drug Delivery Devices Sales by Product
    • 4.2 Global Implantable Drug Delivery Devices Revenue by Product
    • 4.3 Implantable Drug Delivery Devices Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Implantable Drug Delivery Devices Breakdown Data by End User

    6 North America

    • 6.1 North America Implantable Drug Delivery Devices by Countries
      • 6.1.1 North America Implantable Drug Delivery Devices Sales by Countries
      • 6.1.2 North America Implantable Drug Delivery Devices Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Implantable Drug Delivery Devices by Product
    • 6.3 North America Implantable Drug Delivery Devices by End User

    7 Europe

    • 7.1 Europe Implantable Drug Delivery Devices by Countries
      • 7.1.1 Europe Implantable Drug Delivery Devices Sales by Countries
      • 7.1.2 Europe Implantable Drug Delivery Devices Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Implantable Drug Delivery Devices by Product
    • 7.3 Europe Implantable Drug Delivery Devices by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Implantable Drug Delivery Devices by Countries
      • 8.1.1 Asia Pacific Implantable Drug Delivery Devices Sales by Countries
      • 8.1.2 Asia Pacific Implantable Drug Delivery Devices Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Implantable Drug Delivery Devices by Product
    • 8.3 Asia Pacific Implantable Drug Delivery Devices by End User

    9 Central & South America

    • 9.1 Central & South America Implantable Drug Delivery Devices by Countries
      • 9.1.1 Central & South America Implantable Drug Delivery Devices Sales by Countries
      • 9.1.2 Central & South America Implantable Drug Delivery Devices Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Implantable Drug Delivery Devices by Product
    • 9.3 Central & South America Implantable Drug Delivery Devices by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Implantable Drug Delivery Devices by Countries
      • 10.1.1 Middle East and Africa Implantable Drug Delivery Devices Sales by Countries
      • 10.1.2 Middle East and Africa Implantable Drug Delivery Devices Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Implantable Drug Delivery Devices by Product
    • 10.3 Middle East and Africa Implantable Drug Delivery Devices by End User

    11 Company Profiles

    • 11.1 Allergan Inc.
      • 11.1.1 Allergan Inc. Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Allergan Inc. Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Allergan Inc. Implantable Drug Delivery Devices Products Offered
      • 11.1.5 Allergan Inc. Recent Development
    • 11.2 Bayer HealthCare
      • 11.2.1 Bayer HealthCare Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Bayer HealthCare Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Bayer HealthCare Implantable Drug Delivery Devices Products Offered
      • 11.2.5 Bayer HealthCare Recent Development
    • 11.3 Medtronic Inc.
      • 11.3.1 Medtronic Inc. Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Medtronic Inc. Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Medtronic Inc. Implantable Drug Delivery Devices Products Offered
      • 11.3.5 Medtronic Inc. Recent Development
    • 11.4 Nucletron
      • 11.4.1 Nucletron Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Nucletron Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Nucletron Implantable Drug Delivery Devices Products Offered
      • 11.4.5 Nucletron Recent Development
    • 11.5 Merck
      • 11.5.1 Merck Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Merck Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Merck Implantable Drug Delivery Devices Products Offered
      • 11.5.5 Merck Recent Development
    • 11.6 PSivida Corp.
      • 11.6.1 PSivida Corp. Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 PSivida Corp. Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 PSivida Corp. Implantable Drug Delivery Devices Products Offered
      • 11.6.5 PSivida Corp. Recent Development
    • 11.7 Boston Scientific Corporation
      • 11.7.1 Boston Scientific Corporation Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Boston Scientific Corporation Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Boston Scientific Corporation Implantable Drug Delivery Devices Products Offered
      • 11.7.5 Boston Scientific Corporation Recent Development
    • 11.8 Abbott Laboratories
      • 11.8.1 Abbott Laboratories Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Abbott Laboratories Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Abbott Laboratories Implantable Drug Delivery Devices Products Offered
      • 11.8.5 Abbott Laboratories Recent Development
    • 11.9 Bausch and Lomb Inc.
      • 11.9.1 Bausch and Lomb Inc. Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Bausch and Lomb Inc. Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Bausch and Lomb Inc. Implantable Drug Delivery Devices Products Offered
      • 11.9.5 Bausch and Lomb Inc. Recent Development

    12 Future Forecast

    • 12.1 Implantable Drug Delivery Devices Market Forecast by Regions
      • 12.1.1 Global Implantable Drug Delivery Devices Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Implantable Drug Delivery Devices Revenue Forecast by Regions 2019-2025
    • 12.2 Implantable Drug Delivery Devices Market Forecast by Product
      • 12.2.1 Global Implantable Drug Delivery Devices Sales Forecast by Product 2019-2025
      • 12.2.2 Global Implantable Drug Delivery Devices Revenue Forecast by Product 2019-2025
    • 12.3 Implantable Drug Delivery Devices Market Forecast by End User
    • 12.4 North America Implantable Drug Delivery Devices Forecast
    • 12.5 Europe Implantable Drug Delivery Devices Forecast
    • 12.6 Asia Pacific Implantable Drug Delivery Devices Forecast
    • 12.7 Central & South America Implantable Drug Delivery Devices Forecast
    • 12.8 Middle East and Africa Implantable Drug Delivery Devices Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Implantable Drug Delivery Devices Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Implantable drug delivery devices are used to administer drugs and fluids without the repeated insertion of needles. This product circumvents the need for patients to be hospitalized for intravenous infusion.
      Rise in incidence of chronic conditions is creating need for efficient medication delivery. Cancer results in highest number of deaths globally, raising the clinical urgency to adopt advanced alternatives, such as implantable drug delivery devices.
      The global Implantable Drug Delivery Devices market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Implantable Drug Delivery Devices market based on company, product type, end user and key regions.

      This report studies the global market size of Implantable Drug Delivery Devices in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Implantable Drug Delivery Devices in these regions.
      This research report categorizes the global Implantable Drug Delivery Devices market by top players/brands, region, type and end user. This report also studies the global Implantable Drug Delivery Devices market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Allergan Inc.
      Bayer HealthCare
      Medtronic Inc.
      Nucletron
      Merck
      PSivida Corp.
      Boston Scientific Corporation
      Abbott Laboratories
      Bausch and Lomb Inc.

      Market size by Product
      Biodegradable
      Non-biodegradable
      Market size by End User
      Contraception
      Ophthalmology
      Cardiovascular
      Diabetes
      Oncology
      Autoimmune Diseases
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Implantable Drug Delivery Devices market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Implantable Drug Delivery Devices market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Implantable Drug Delivery Devices companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Implantable Drug Delivery Devices submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Implantable Drug Delivery Devices are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Implantable Drug Delivery Devices market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now